United States
LocationRelationship Network
Event Timeline
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Bryan
|
Legal representative |
5
|
1 | |
|
person
Edwards
|
Legal representative |
5
|
1 | |
|
person
George
|
Legal representative |
5
|
1 | |
|
person
Giffen
|
Legal representative |
5
|
1 | |
|
person
Libby
|
Legal representative |
5
|
1 | |
|
person
Lloyd
|
Legal representative |
5
|
1 | |
|
person
Maniktala
|
Legal representative |
5
|
1 | |
|
person
Marshall
|
Legal representative |
5
|
1 | |
|
person
McGuinness
|
Legal representative |
5
|
1 | |
|
person
Paxson
|
Legal representative |
5
|
1 | |
|
person
Poindexter
|
Legal representative |
5
|
1 | |
|
person
Safavian
|
Legal representative |
5
|
1 | |
|
person
Katz
|
Legal representative |
5
|
1 | |
|
person
Tellier
|
Legal representative |
5
|
1 | |
|
person
Wicker
|
Legal representative |
5
|
1 | |
|
person
Walker
|
Legal representative |
5
|
1 | |
|
person
Walsh
|
Legal representative |
5
|
1 | |
|
person
Washington
|
Legal representative |
5
|
1 | |
|
person
Watson
|
Legal representative |
5
|
1 | |
|
person
Wedd
|
Legal representative |
5
|
1 | |
|
person
Weiner
|
Legal representative |
5
|
1 | |
|
person
Werner
|
Legal representative |
5
|
1 | |
|
person
Wey
|
Legal representative |
5
|
1 | |
|
person
Winter
|
Legal representative |
5
|
1 | |
|
person
Wong
|
Legal representative |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Return to Afghanistan to oust Taliban regime | Afghanistan | View |
| N/A | Extradition proceedings | Proceedings in England and Wales in relation to US extradition requests for Ghislaine Maxwell. | England and Wales | View |
| N/A | N/A | Syrian civil uprising and potential use of chemical weapons by the Assad regime | Syria | View |
| N/A | N/A | U.S. involvement in Libya | Libya | View |
| N/A | N/A | Diplomatic crisis involving Israel, Turkey, and the U.S. | International | View |
| N/A | N/A | War with Iran | Iran | View |
| N/A | N/A | Potential military campaign against Iran | Iran | View |
| N/A | N/A | Proposed joint intelligence estimate session | Unspecified | View |
| N/A | N/A | Potential conflict with Iran | Middle East / Global | View |
| N/A | N/A | Signing of an agreement where Epstein acknowledges conditions, waives certain rights, and consent... | N/A | View |
| N/A | N/A | United States subjected South Korea to steel and aluminum tariffs. | N/A | View |
| N/A | N/A | Intensification of the trade war between the United States and China. | N/A | View |
| 2025-12-23 | N/A | China hit U.S. with $60 bn worth of tariffs | Global/Trade | View |
| 2025-11-19 | N/A | North Korea's mission to the UN accused the United States of being hell-bent on hostile acts. | United Nations | View |
| 2025-11-19 | N/A | North Korea’s mission to the UN accused the US of being 'hell-bent' on hostile acts. | United Nations | View |
| 2025-11-17 | N/A | U.S. slapped $200 bn worth of tariffs on China | Global/Economic | View |
| 2024-11-25 | N/A | Rehearing denied for United States v. Maxwell, 118 F.4th 256 (2d Cir. 2024). | Second Circuit | View |
| 2024-09-17 | N/A | Judgment entered for United States v. Maxwell, 118 F.4th 256 (2d Cir. 2024). | Second Circuit | View |
| 2024-01-01 | N/A | United States v. Maxwell, 118 F.4th 256 (2d Cir. 2024) case cited. | Second Circuit | View |
| 2024-01-01 | Legal decision | Decision in the case United States v. Johnson, 93 F.4th 605 (2024). | N/A | View |
| 2024-01-01 | N/A | U.S. v. Maxwell Decision | Second Circuit Court of App... | View |
| 2023-03-12 | Court argument | Argument date for the case United States v. Ghislaine Maxwell, Docket No. 22-1426. | United States Court of Appe... | View |
| 2023-02-07 | N/A | Legal case: United States v. Amani Investments, No. 2:23-cr-00014-JAM, ECF No. 8 | E.D. Cal. | View |
| 2023-01-01 | Legal case | Citation of United States v. Montague, 67 F.4th 520 (2d Cir. 2023). | 2d Cir. | View |
| 2023-01-01 | Legal proceeding | Court case: United States v. Nieves | 2d Cir. | View |
HOUSE_OVERSIGHT_024665.jpg
This document is page 29 of a 2017 investment report by Ackrell Capital regarding 'Cannabis Science 101.' The text discusses synthetic cannabinoids (mentioning Marinol/dronabinol), the 'entourage effect,' and general safety and dosage guidelines for cannabis use. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024665,' indicating it was produced as evidence in a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024656.jpg
This document is page 20 of a Cannabis Investment Report dated December 2017, produced by Ackrell Capital, LLC. It details scientific information regarding cannabinoids, specifically contrasting THC and CBD, and provides a matrix of medical conditions (such as Cancer, ALS, and Glaucoma) alongside the specific cannabinoids used to treat them. The document bears a 'HOUSE_OVERSIGHT_024656' Bates stamp, indicating it was part of a document production for the House Oversight Committee, though the text itself contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024649.jpg
This document is page 13 of an Executive Summary from a 2017 Ackrell Capital investment report regarding the cannabis industry. It discusses the increase in strategic investor activity, citing investments by Constellation Brands and Scotts Miracle-Gro, while noting a continuing funding gap due to a lack of institutional support. The document outlines the investment outlook, noting that while billions were raised in 2017, most companies are in early development stages with revenues under $5 million. The document bears a 'HOUSE_OVERSIGHT_024649' stamp, suggesting it is part of a larger document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024647.jpg
This document is page 11 of a 2017 Ackrell Capital executive summary report analyzing the cannabis industry. It discusses market dynamics, specifically the anticipated supply from South America, and details the significant banking challenges U.S. cannabis companies face due to federal laws and the Bank Secrecy Act (BSA), referencing FinCEN data on Suspicious Activity Reports (SARs). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, though the text itself does not mention Jeffrey Epstein.
HOUSE_OVERSIGHT_024646.jpg
This page from an Ackrell Capital report discusses the potential first FDA approval of a cannabis-derived pharmaceutical (Epidiolex) in 2018 and its implications. It also analyzes the commoditization of cannabis flower, noting a downward pricing trend in legalized states like Colorado, Oregon, and Washington, illustrated by a graph of prices from 2016 to 2017.
HOUSE_OVERSIGHT_024644.jpg
This document is page 8 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It analyzes the growth of the legal cannabis markets in California and Canada, predicting significant expansion in 2018 due to legislative changes like the Cannabis Act. The report also discusses the evolution of consumer products towards 'mainstream' acceptance, highlighting innovations in product types (concentrates, infused products) and the increasing sophistication of dispensaries and branding.
HOUSE_OVERSIGHT_024643.jpg
This document is page 7 of an executive summary by Ackrell Capital regarding the U.S. Legalized Cannabis Market. It contains a chart projecting market growth and consumer numbers from 2016 to 2030. The text focuses on trends to watch in 2018, specifically the impact of recreational legalization in California and Canada. The document bears a 'HOUSE_OVERSIGHT_024643' stamp, but the content is strictly related to cannabis market analysis and contains no mention of Jeffrey Epstein or related associates.
HOUSE_OVERSIGHT_024642.jpg
This page from a 2017 Ackrell Capital investment report outlines a six-step prediction for the federal legalization of cannabis in the United States. It details specific milestones involving the FDA and legislative changes, projecting a timeline where full legalization occurs by 2027, which would serve as a major catalyst for market growth.
HOUSE_OVERSIGHT_024641.jpg
This document is page 5 of an executive summary from a 2017 report by Ackrell Capital, LLC regarding the cannabis industry. It features a text summary and a circular infographic detailing federal laws and policies impacting the industry, categorized into Drug and Food Regulation, Banking and Finance, and Intellectual Property. The document bears a 'HOUSE_OVERSIGHT_024641' Bates stamp, indicating it was part of a document production to the House Oversight Committee.
HOUSE_OVERSIGHT_024640.jpg
This document is page 4 of a Cannabis Investment Report by Ackrell Capital dated December 2017. It analyzes the U.S. state-legal cannabis market, estimating a total value of $8.0 billion with specific breakdowns for California, Colorado, Washington, and Oregon. The text discusses the legal conflict between state legalization and federal prohibition, noting the lack of bankruptcy protections and banking access, while highlighting DOJ and Treasury policies that have allowed the industry to operate. The document contains the Bates stamp HOUSE_OVERSIGHT_024640, indicating it is part of a House Oversight Committee production.
HOUSE_OVERSIGHT_024639.jpg
This document is page 3 of a market report by Ackrell Capital regarding the U.S. state-legal cannabis market. It summarizes the conflict between federal prohibition and state legalization, categorizing state laws into medical, CBD/limited, and recreational use as of January 2018. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the U.S. House Oversight Committee.
HOUSE_OVERSIGHT_024638.jpg
This page is extracted from a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It provides a market overview, projecting the U.S. cannabis market to exceed $100 billion annually and the global market to reach $500 billion. The document discusses global legalization trends, medicinal benefits, and includes a map illustrating countries with various levels of cannabis legalization as of January 2018. The document bears the Bates stamp HOUSE_OVERSIGHT_024638, indicating it was part of a document production to the House Oversight Committee, though no specific mentions of Jeffrey Epstein appear on this single page.
HOUSE_OVERSIGHT_024637.jpg
This document is an executive summary from a 2017 Ackrell Capital investment report regarding the global cannabis market. It analyzes market size, consumer statistics from the UNODC and RAND Corporation, and projects future growth based on anticipated federal legalization in the United States. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely obtained as part of a congressional investigation, though no specific individuals (Epstein or otherwise) are mentioned on this specific page.
HOUSE_OVERSIGHT_024635.jpg
This document is the foreword to the Ackrell Capital 2018 Cannabis Investment Report, dated December 28, 2017. It outlines the growth of the cannabis industry, recent legalization efforts in the US, Canada, and Germany, and market predictions. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, the text itself contains no direct mention of Jeffrey Epstein, Ghislaine Maxwell, or specific transactions related to them.
HOUSE_OVERSIGHT_024634.jpg
This document is a slide from a 2017 market research presentation by Ackrell Capital, LLC regarding the U.S. Legalized Cannabis Market. It features a chart projecting market growth and consumer numbers through 2030, contingent on federal legalization milestones, and a diagram categorized by industry segments (Production, Business Solutions, Distribution, Digital Media, and Consumer Products). The document bears the Bates stamp HOUSE_OVERSIGHT_024634, indicating it is part of a larger evidence collection.
HOUSE_OVERSIGHT_024633.jpg
This document is a presentation slide produced by Ackrell Capital, LLC in 2017, displaying the 'Progression of U.S. State Cannabis Laws.' It features six maps of the United States showing the legislative status of cannabis (Recreational, Medical, CBD/Limited) across the years 1996, 2004, 2008, 2012, 2014, and 2017 ('Today'). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating its inclusion in a U.S. House of Representatives Oversight Committee investigation.
HOUSE_OVERSIGHT_024632.jpg
This document is a page from an investment report produced by Ackrell Capital, LLC, dated roughly January 2018 (copyright 2017). It features two maps analyzing the legal status of cannabis globally and within the United States, distinguishing between recreational, medical, and limited access laws. The document bears a 'HOUSE_OVERSIGHT_024632' Bates stamp, indicating it was part of a document production for a US House Oversight Committee investigation, likely related to financial records or due diligence files, though Jeffrey Epstein is not explicitly named on this specific page.
HOUSE_OVERSIGHT_024631.jpg
This document is the cover and executive summary page of the '2018 Cannabis Investment Report' produced by Ackrell Capital, an investment bank based in San Francisco. It details global cannabis consumption statistics, the legal landscape in the U.S. and globally, and financial market estimates (predicting the legal market could exceed $100 billion). The document bears the Bates stamp 'HOUSE_OVERSIGHT_024631', indicating it was part of a document production for a House Oversight Committee investigation.
HOUSE_OVERSIGHT_024622.jpg
This document page (likely part of a House Oversight file) discusses geopolitical strategies regarding the admission of Palestine into the United Nations. It analyzes the legal hurdles presented by the US veto power in the Security Council and proposes alternative procedures involving the General Assembly and the International Court of Justice to pressure for statehood and an end to the 1967 occupation. The text is a policy analysis rather than a correspondence log.
HOUSE_OVERSIGHT_024613.jpg
This document page (labeled 22 and Bates stamped HOUSE_OVERSIGHT_024613) contains a political commentary text authored by Dimitri K. Simes, President of The Nixon Center. The text argues that while Russian corruption is serious, the U.S. should not let focusing on it endanger the relationship with Russia, especially given U.S. involvement with corrupt governments in Iraq and Afghanistan. It concludes by noting the shrinking margin for error in U.S. leadership amidst rising global powers.
HOUSE_OVERSIGHT_024612.jpg
This page, marked with a House Oversight Bates stamp, appears to be an excerpt from a policy paper or article analyzing U.S. foreign policy under the Obama administration. It discusses the complexities of U.S. relations with China and Russia, specifically focusing on the failed 'reset' with Russia, tensions over the death of Sergei Magnitsky, and the strategic implications of a potential Russia-China alliance. The text highlights the administration's struggle to balance human rights concerns with geopolitical cooperation regarding Iran and Afghanistan.
HOUSE_OVERSIGHT_024611.jpg
This document appears to be page 20 of a larger geopolitical analysis or article (likely from 2011) found within House Oversight Committee files. It critiques US foreign policy, specifically discussing the delicate balance of relations with Pakistan and the incoherent strategy toward China's rise. The author contrasts the policy recommendations of Henry Kissinger (cooperation) and Aaron Friedberg (containment), expressing a preference for Kissinger's view while criticizing the Obama administration for indecision.
HOUSE_OVERSIGHT_024596.jpg
This document page appears to be a transcript from a House Oversight Committee investigation (indicated by the footer). It features an interview with an author who wrote a profile in 'Foreign Policy' magazine regarding Muammar Qadhafi. The text analyzes Qadhafi's psychological state, describing him as having a 'borderline personality' that fluctuates between feeling invulnerable when succeeding (e.g., marching on Benghazi) and adopting a 'noble Arab warrior' persona when failing or under pressure.
HOUSE_OVERSIGHT_024581.jpg
This document creates a management profile for a company called KUE, likely part of a larger offering memorandum or business proposal. It details the biographies of the three principals: Michael Milken (Chairman), Steven Green (Vice Chairman), and Lowell Milken (CEO), highlighting their philanthropic work, past business leadership (Samsonite, Heron International), and government service (Green's ambassadorship). The document bears a House Oversight Bates stamp, indicating it was part of a congressional inquiry.
HOUSE_OVERSIGHT_024577.jpg
This document appears to be page 144 of a legal or financial agreement (likely an offering memorandum) concerning an entity named 'KUE'. It details tax implications for partners, specifically regarding 'Gain on Sale', 'U.S. Real Property Holding Corporation' (USRPHC) status, and backup withholding rules. It also outlines strict reporting requirements for nominees holding interests on behalf of beneficial owners. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it is part of a congressional investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity